Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04451135 · ClinicalTrials.gov registry record · NA
CET- REM (Correlating ECT Response to EEG Markers)
A NA study of Treatment-Resistant Depression and ECT, sponsored by Washington University School of Medicine.
- Active
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT04451135 is a NA study of Treatment-Resistant Depression and ECT that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 31 participants, below the 373-participant average among 54 other Treatment-Resistant Depression trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04451135, a NA study of Treatment-Resistant Depression and ECT, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
Single-center study to determine the relationship between changes in depression symptoms and electroencephalographic (EEG) patterns induced by electroconvulsive therapy (ECT)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Electroencephalographic (EEG)
- DIAGNOSTIC_TEST Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR16)
- DIAGNOSTIC_TEST Ictal Electroencephalographic (EEG) Measurements
- DIAGNOSTIC_TEST Post-Ictal Electroencephalographic (EEG) Suppression Measurements
Study Locations (1)
Missouri
- Washington University School of Medicine/Barnes-Jewish Hospital - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-10-09 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04451135
The ClinicalTrials.gov registry entry for NCT04451135 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 373-participant average among 54 other Treatment-Resistant Depression trials with a reported enrollment target (92% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Treatment-Resistant Depression appearing as the primary indexed condition, and to 4 interventions - of which Electroencephalographic (EEG) is the first listed.
NCT04451135 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04451135 about?
NCT04451135 is a clinical study titled "CET- REM (Correlating ECT Response to EEG Markers)". Single-center study to determine the relationship between changes in depression symptoms and electroencephalographic (EEG) patterns induced by electroconvulsive therapy (ECT)
What is the current status of trial NCT04451135?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2020-10-09. Estimated completion is 2027-06.
What conditions does trial NCT04451135 study?
This clinical trial studies the following conditions: Treatment-Resistant Depression, ECT.
What interventions are being tested in trial NCT04451135?
The interventions under investigation include: Electroencephalographic (EEG) (DIAGNOSTIC_TEST), Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR16) (DIAGNOSTIC_TEST), Ictal Electroencephalographic (EEG) Measurements (DIAGNOSTIC_TEST), Post-Ictal Electroencephalographic (EEG) Suppression Measurements (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04451135?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04451135 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Treatment-Resistant Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression
RECRUITING · NA
-
Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective Processing
RECRUITING · NA
-
DBS for TRD With the Medtronic Percept PC
RECRUITING · NA
-
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
RECRUITING · NA
-
PCS in Severe Treatment Resistant Depression
RECRUITING · NA
-
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.